Medical Specialties Industry Financials, Performance and Ratios
-
Industry Score
40.0 /100
Rank 41 out of 131 Industries -
Advance/Decline
117/90
-
No. of Companies207
-
Avg. Market Cap8,828
-
Price to Earning Ratio33.87
-
Price to Earning Growth Ratio13.98
-
Price to Book Ratio43.57
-
Return on Equity12.71
-
Return on Capital Employed-
-
Return on Assets7.24
-
Dividend yield 1 year %0.20 %
-
Net Profit Growth Annual YoY %-6.48 %
-
Net Profit Growth Qtr YoY %33.15 %
-
Net Profit Growth Qtr QoQ %32.96 %
Show more
*All values are market cap weighted averages.
*All Financial parameters are in Million USD.
Medical Specialties Industry Market Breadth
- < -5%
- -2 to -5%
- 0 to -2%
- 0 to 2%
- 2 to 5%
- > 5%
Medical Specialties Peer comparison
Compare all stocks in Medical Specialties industry listed on stock exchanges
| Stock Name | 3M Price Chart | Market Cap | LTPLast Traded Price | Day High Low (%) | Week High Low (%) | Month High Low (%) | Qtr High Low(%) | 1 Year High low(%) | 3 Year High low(%) | 5 Year High low(%) | 10 Year High low(%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Agilent Tech |
|
47,302.0
|
167.8
|
L
 0.7%
H
166.3
170.2
|
L
 -2.9%
H
166.1
177.1
|
L
 11.2%
H
141.3
177.1
|
L
 28.4%
H
125
177.1
|
L
 18.5%
H
108.4
177.1
|
L
 50.2%
H
96.4
177.1
|
L
 10.1%
H
96.4
177.1
|
L
 258.3%
H
42.9
179.6
|
| Abbott |
|
168,712.4
|
97.5
|
L
 0.8%
H
95.1
97.6
|
L
 -3.7%
H
95.1
101.8
|
L
 -10%
H
95.1
108.4
|
L
 2.2%
H
87.6
117.3
|
L
 -27.6%
H
82.0
135.2
|
L
 1.9%
H
82.0
141.2
|
L
 -15.6%
H
82.0
142.6
|
L
 131.6%
H
37.4
142.6
|
| Alcon Inc - Registered Shares |
|
30,821.6
|
63.8
|
L
 -0.3%
H
63.5
64.4
|
L
 -1.1%
H
63.4
65.5
|
L
 -9.6%
H
63.4
69.6
|
L
 -8.5%
H
63.4
76.2
|
L
 -17.6%
H
61.8
87.6
|
L
 -14.9%
H
61.8
101.1
|
L
 -18.5%
H
55.2
101.1
|
L
H
39.4
101.1
|
| Artivion Inc |
|
1,087.8
|
22.3
|
L
 1.7%
H
21.6
22.7
|
L
 -1.4%
H
21.6
23.2
|
L
 -12.8%
H
21.6
25.8
|
L
 -6.9%
H
21.6
30.1
|
L
 -45.7%
H
19.2
48.3
|
L
 50.4%
H
12.2
48.3
|
L
 -0.4%
H
9.6
48.3
|
L
 29.0%
H
9.6
48.3
|
| Avantor Inc |
|
10,375.3
|
15.3
|
L
 2.1%
H
15.0
15.4
|
L
 0.6%
H
14.6
15.4
|
L
 1.0%
H
14.6
16.1
|
L
 48.6%
H
9.7
16.1
|
L
 7.4%
H
7.3
16.1
|
L
 -25.3%
H
7.3
28
|
L
 -63.1%
H
7.3
42.5
|
L
H
6.7
44.4
|
| Baxter International |
|
12,144.2
|
23.5
|
L
 -0.6%
H
23.4
23.9
|
L
 0.5%
H
23.1
24.1
|
L
 -8.1%
H
22.6
26.1
|
L
 3.7%
H
21.2
30
|
L
 -1.6%
H
15.7
30
|
L
 -36.1%
H
15.7
44
|
L
 -71.1%
H
15.7
89.7
|
L
 -50.7%
H
15.7
95.2
|
| Becton, Dickinson and Co. |
|
48,158.0
|
176.8
|
L
 -0.7%
H
175.7
178.1
|
L
 -3.8%
H
175.7
184.3
|
L
 -5.8%
H
175.2
187.1
|
L
 11.8%
H
148.2
193.1
|
L
 -8.7%
H
140.1
213.1
|
L
 -31.7%
H
140.1
269.5
|
L
 -25.9%
H
140.1
287.3
|
L
 1.6%
H
140.1
287.3
|
| Butterfly Network Inc (Class A) |
|
2,383.3
|
9.0
|
L
 4.9%
H
8.6
9.0
|
L
 -4.7%
H
8.5
10.0
|
L
 21.6%
H
7.0
10.1
|
L
 16.5%
H
6.4
10.1
|
L
 284.1%
H
1.9
10.1
|
L
 721.1%
H
0.7
10.1
|
L
 -15.0%
H
0.7
11.5
|
L
H
0.7
29.1
|
| Bio-Rad Laboratories Inc (Class A) |
|
9,870.1
|
369.1
|
L
 3.8%
H
357.3
369.4
|
L
 -3.1%
H
353.3
384.0
|
L
 -4.4%
H
353.3
390.7
|
L
 24.4%
H
281.8
396.2
|
L
 20.8%
H
236.7
396.2
|
L
 3.9%
H
211.4
396.2
|
L
 -49.4%
H
211.4
799.0
|
L
 127.6%
H
154.9
832.7
|
| Bausch + Lomb Corp |
|
6,111.1
|
17.1
|
L
 1%
H
16.8
17.2
|
L
 1.5%
H
16.6
17.3
|
L
 -5.2%
H
16.6
18.2
|
L
 -0.3%
H
15.6
18.5
|
L
 12.6%
H
13.8
18.9
|
L
 2.1%
H
10.5
21.7
|
L
H
10.5
22.0
|
L
H
10.5
22.0
|
| Boston Scientific |
|
61,737.2
|
42.6
|
L
 -1.5%
H
41.9
43.4
|
L
 -3.0%
H
41.9
44.3
|
L
 -10.9%
H
41.9
47.5
|
L
 -5.6%
H
41.9
53.0
|
L
 -56.2%
H
41.9
105.7
|
L
 -17.4%
H
41.9
109.5
|
L
 0.4%
H
35.0
109.5
|
L
 83.0%
H
19.7
109.5
|
| Conmed Corp |
|
1,387.3
|
46.3
|
L
 0.9%
H
46.2
47.1
|
L
 2.1%
H
44.5
47.2
|
L
 -6.1%
H
44.4
49.1
|
L
 36.9%
H
32.6
53.7
|
L
 -3.8%
H
31.4
53.7
|
L
 -52.3%
H
31.4
117.3
|
L
 -64.3%
H
31.4
159.1
|
L
 15.9%
H
31.4
159.1
|
| Cooper Companies |
|
10,821.7
|
56.9
|
L
 -0.9%
H
56.7
57.7
|
L
 2.8%
H
54.6
57.7
|
L
 -18.2%
H
51.0
69.0
|
L
 -23.3%
H
51.0
78.1
|
L
 -19.2%
H
51.0
89.8
|
L
 -27.7%
H
51.0
112.4
|
L
 -44.3%
H
51.0
112.4
|
L
 28.7%
H
39.7
115.9
|
| Danaher |
|
150,481.2
|
214.1
|
L
 1.1%
H
212.0
216.1
|
L
 -4.7%
H
211.2
228.4
|
L
 3.1%
H
199.1
228.4
|
L
 8.2%
H
165.8
228.4
|
L
 -0.4%
H
160.9
242.8
|
L
 -0.9%
H
160.9
281.7
|
L
 -28.3%
H
160.9
331.7
|
L
 175.6%
H
75.7
334.0
|
| Enovis Corp |
|
1,024.8
|
17.8
|
L
 -1.6%
H
17.7
18.3
|
L
 -3.7%
H
17.7
18.7
|
L
 -4.3%
H
17.3
20.2
|
L
 -21.0%
H
17.3
31.7
|
L
 -44.5%
H
17.3
34.3
|
L
 -64.6%
H
17.3
65.0
|
L
H
17.3
72.1
|
L
H
17.3
72.1
|
| Edwards Lifesciences |
|
49,080.5
|
85.2
|
L
 -0.1%
H
84.7
86.5
|
L
 -1.3%
H
84.5
88.2
|
L
 -5.3%
H
83.8
89.7
|
L
 -9.8%
H
81.2
96.3
|
L
 10.5%
H
72.3
96.3
|
L
 19.5%
H
58.9
96.3
|
L
 -19.9%
H
58.9
131.7
|
L
 114.4%
H
27.0
131.7
|
| Glaukos Corp |
|
9,658.6
|
163.8
|
L
 0.4%
H
163.0
168.1
|
L
 6.0%
H
151.7
168.7
|
L
 -7.7%
H
151.0
185.4
|
L
 10.4%
H
143.1
191.6
|
L
 87.3%
H
73.2
191.6
|
L
 136.5%
H
59.2
191.6
|
L
 254.9%
H
33.3
191.6
|
L
 327.2%
H
23.1
191.6
|
| Globus Medical Inc (Class A) |
|
10,150.2
|
75.6
|
L
 1.6%
H
74.2
76.2
|
L
 1.5%
H
73.7
76.2
|
L
 -3.4%
H
72.8
78.3
|
L
 -5.6%
H
72.8
88.9
|
L
 25%
H
56.5
101.4
|
L
 49.3%
H
43.4
101.4
|
L
 -1.7%
H
43.4
101.4
|
L
 234.8%
H
19.3
101.4
|
| Haemonetics Corp |
|
4,762.6
|
104.7
|
L
 0.3%
H
103.6
105.7
|
L
 -0.6%
H
103.5
106.7
|
L
 1.7%
H
100.5
110.5
|
L
 39.4%
H
71.8
110.5
|
L
 107.3%
H
48.2
110.5
|
L
 21.0%
H
47.3
110.5
|
L
 48.9%
H
43.5
110.5
|
L
 187.7%
H
32.8
142.1
|
| Inspire Medical Systems Inc |
|
2,022.9
|
70.0
|
L
 -1.1%
H
68.4
71.7
|
L
 -0.8%
H
68.4
75.3
|
L
 10.9%
H
61.6
78.8
|
L
 49.0%
H
46.5
78.8
|
L
 -8.6%
H
38.9
147.0
|
L
 -62.2%
H
38.9
257.4
|
L
 -70.2%
H
38.9
330
|
L
H
22.5
330
|
| Integer Holdings Corp |
|
4,298.9
|
126.5
|
L
 0.0%
H
126.4
126.5
|
L
 0.1%
H
126.2
126.5
|
L
 0.0%
H
125.9
126.5
|
L
 32.9%
H
90.2
126.8
|
L
 20.4%
H
62
126.8
|
L
 62.6%
H
62
146.4
|
L
 38.9%
H
50.1
146.4
|
L
 485.7%
H
18.1
146.4
|
| Medtronic |
|
110,491.9
|
86.4
|
L
 -0.1%
H
85.6
87.9
|
L
 -2.6%
H
85.2
89.5
|
L
 -8.3%
H
85.2
94.7
|
L
 3.8%
H
79.0
95.4
|
L
 -11.6%
H
73.3
106.3
|
L
 13.3%
H
68.9
106.3
|
L
 -30.9%
H
68.9
128.9
|
L
 0.3%
H
68.9
135.9
|
| Mettler-Toledo International |
|
29,778.1
|
1,486.2
|
L
 0.3%
H
1480.2
1501.9
|
L
 -1.7%
H
1473.8
1554.8
|
L
 10.5%
H
1266.6
1554.8
|
L
 13.6%
H
1216.9
1554.8
|
L
 13.1%
H
1023.1
1554.8
|
L
 36.1%
H
928.5
1554.8
|
L
 8.3%
H
928.5
1714.8
|
L
 257.4%
H
395.6
1714.8
|
| Envista Holdings Corp |
|
3,768.1
|
23.5
|
L
 1.3%
H
23.1
23.7
|
L
 -2.1%
H
22.8
24.1
|
L
 -14%
H
22.8
27.4
|
L
 -15.1%
H
22.8
29
|
L
 12.5%
H
18.8
30.4
|
L
 -13.1%
H
14.2
30.4
|
L
 -44.4%
H
14.2
52.0
|
L
H
10.1
52.0
|
| Owens & Minor Inc |
|
38.5
|
0.5
|
L
 -10.7%
H
0.5
0.6
|
L
 -29.6%
H
0.5
0.7
|
L
 -58.7%
H
0.5
1.2
|
L
 -86.1%
H
0.5
3.8
|
L
 -89.5%
H
0.5
5.6
|
L
 -96.8%
H
0.5
28.4
|
L
 -98.5%
H
0.5
49.1
|
L
 -98.5%
H
0.5
49.2
|
| Penumbra Inc |
|
12,508.1
|
317.6
|
L
 -0.1%
H
316.8
318.4
|
L
 -0.4%
H
316.8
319.3
|
L
 -1.4%
H
316.8
322.6
|
L
 -0.3%
H
315.7
328.6
|
L
 24.0%
H
221.3
362.4
|
L
 37.4%
H
148
362.4
|
L
 24.3%
H
114.9
362.4
|
L
 328.0%
H
56.1
362.4
|
| Perkinelmer Inc |
|
-
|
151.5
|
L
 1.7%
H
148.6
153.4
|
L
 0.3%
H
148.1
158.3
|
L
 16.4%
H
120.9
158.3
|
L
 33.2%
H
102.4
158.3
|
L
 61.1%
H
81.2
158.3
|
L
 62.5%
H
81.2
158.3
|
L
 -11.4%
H
81.2
201.1
|
L
 171.7%
H
45.4
201.1
|
| Qiagen NV |
|
9,240.7
|
44.8
|
L
 6.5%
H
42.2
45.6
|
L
 1.3%
H
41.9
45.6
|
L
 2.9%
H
41.7
45.6
|
L
 11.6%
H
37.7
45.6
|
L
 -9.2%
H
32.5
57.8
|
L
 -0.2%
H
32.5
57.8
|
L
 -20.8%
H
32.5
64.7
|
L
 41.6%
H
27.8
65.9
|
| ResMed |
|
30,784.5
|
218.9
|
L
 -1.0%
H
218.0
223.7
|
L
 -1.4%
H
218.0
224.2
|
L
 -4.1%
H
215.8
234.3
|
L
 4.4%
H
190.2
242.4
|
L
 -21.4%
H
180.3
284.9
|
L
 47.9%
H
132.2
293.8
|
L
 -14.2%
H
132.2
293.8
|
L
 241.4%
H
56.6
301.3
|
| Silvergate Cap Corp (Class A) |
|
395.8
|
19.0
|
L
 1.4%
H
18.5
19.5
|
L
 11.9%
H
16.6
19.6
|
L
 -6.5%
H
16.6
20.5
|
L
 -10.6%
H
16.6
24.6
|
L
 56.0%
H
10.9
24.6
|
L
 26.7%
H
10.9
24.6
|
L
 -86.0%
H
0.0
239.3
|
L
 6.9%
H
0.0
239.3
|
| Steris PLC |
|
20,332.7
|
208.5
|
L
 -0.4%
H
206.5
210.3
|
L
 -0.2%
H
206.5
212.1
|
L
 -7.2%
H
203.3
223.0
|
L
 -4.4%
H
203.3
241.4
|
L
 -14%
H
195.1
269.4
|
L
 -6.3%
H
195.1
269.4
|
L
 1.2%
H
159.2
269.4
|
L
 191.5%
H
63.8
269.4
|
| Stevanato Grp Spa |
|
5,517.1
|
20.2
|
L
 1.1%
H
19.8
20.5
|
L
 -4.4%
H
19.5
21.6
|
L
 -1.5%
H
19.5
23.3
|
L
 6.3%
H
18.7
23.3
|
L
 -22.3%
H
12.9
28.0
|
L
 -34.1%
H
12.9
35.6
|
L
 -14.6%
H
12.9
36.3
|
L
H
12.9
36.3
|
| Stryker |
|
105,647.5
|
275.4
|
L
 0.9%
H
271.2
277.0
|
L
 1.1%
H
271.1
280.2
|
L
 -9.1%
H
267
301.5
|
L
 -15.7%
H
267
352.5
|
L
 -25.7%
H
267
392.6
|
L
 3.5%
H
250.0
406.2
|
L
 5.0%
H
188.8
406.2
|
L
 136.9%
H
106.5
406.2
|
| Smith & Nephew PLC (ADR) |
|
11,057.2
|
26.4
|
L
 0.6%
H
26.1
26.5
|
L
 -1.8%
H
26.1
27.2
|
L
 -8.5%
H
26.1
29.2
|
L
 -12.7%
H
26.1
32.9
|
L
 -27.3%
H
26.1
37.5
|
L
 11.2%
H
21.5
38.8
|
L
 -23.8%
H
21.5
38.8
|
L
 -19.9%
H
21.5
52.3
|
| Teleflex Incorporated |
|
5,259.3
|
124.1
|
L
 -1.6%
H
124.0
127.1
|
L
 1.7%
H
123.5
128.6
|
L
 -10.3%
H
118.3
139.5
|
L
 -7.4%
H
118.3
145
|
L
 -5.2%
H
100.2
145
|
L
 -36.5%
H
100.2
257.9
|
L
 -66.8%
H
100.2
382.5
|
L
 -24.9%
H
100.2
449.4
|
| Thermo Fisher |
|
242,110.5
|
654.8
|
L
 0.4%
H
648.3
659.5
|
L
 -3.0%
H
648.3
683.6
|
L
 6.7%
H
594.8
683.6
|
L
 25.1%
H
495.0
683.6
|
L
 20.5%
H
435.3
683.6
|
L
 30.3%
H
385.5
683.6
|
L
 15.1%
H
385.5
683.6
|
L
 315.6%
H
139.1
683.6
|
| Waters |
|
41,776.1
|
425.2
|
L
 -0.1%
H
423.4
433.3
|
L
 -1.9%
H
423.4
448.2
|
L
 3.9%
H
393.0
448.2
|
L
 12.1%
H
345.2
448.2
|
L
 29.5%
H
282.8
448.2
|
L
 58.8%
H
231.9
448.2
|
L
 22.3%
H
231.9
448.2
|
L
 168.8%
H
133.4
448.2
|
| West Pharma Services |
|
25,685.7
|
365.0
|
L
 0.0%
H
363.3
368.9
|
L
 -1.5%
H
363.1
378.5
|
L
 7.4%
H
332.0
382.7
|
L
 -0.2%
H
325.3
386
|
L
 33.9%
H
223.8
386
|
L
 -2.4%
H
187.4
413.7
|
L
 -10.9%
H
187.4
475
|
L
 398.3%
H
70.2
475.4
|
| Zimmer Biomet Holdings |
|
16,840.2
|
88.3
|
L
 0.3%
H
87.1
88.8
|
L
 -3.0%
H
87.1
91.8
|
L
 -10.0%
H
87.1
99.2
|
L
 0.9%
H
86.3
102.9
|
L
 -12.4%
H
79.1
106.9
|
L
 -19.5%
H
79.1
133.9
|
L
 -36.1%
H
79.1
149.3
|
L
 -27.4%
H
70.0
169.7
|
| Revvity |
|
16,908.7
|
151.5
|
L
 1.7%
H
148.6
153.4
|
L
 0.3%
H
148.1
158.3
|
L
 16.4%
H
120.9
158.3
|
L
 33.2%
H
102.4
158.3
|
L
 61.1%
H
81.2
158.3
|
L
 41.0%
H
79.5
158.3
|
L
 -11.4%
H
79.5
203.2
|
L
 171.7%
H
45.4
203.2
|
| Aethlon Medical Inc |
|
4.6
|
6.5
|
L
 -2.7%
H
6.4
6.7
|
L
 2.7%
H
6.0
6.7
|
L
 254.4%
H
1.4
9.5
|
L
 808.5%
H
0.5
9.5
|
L
 -18.9%
H
0.5
9.5
|
L
 -95.9%
H
0.5
188
|
L
 -99.8%
H
0.5
3176
|
L
 -100.0%
H
0.5
62160
|
| Airsculpt Tech Inc |
|
127.6
|
1.8
|
L
 4.1%
H
1.7
1.9
|
L
 -9.7%
H
1.6
2.0
|
L
 -36.8%
H
1.6
3
|
L
 -60.8%
H
1.6
5.2
|
L
 -77.1%
H
1.5
12
|
L
 -74.8%
H
1.5
12
|
L
H
1.5
18.5
|
L
H
1.5
18.5
|
| Align Tech |
|
10,211.3
|
143.7
|
L
 -1.1%
H
143.2
147.1
|
L
 -2.1%
H
142.2
147.1
|
L
 -9.4%
H
142.2
156.1
|
L
 -22.1%
H
142.2
191.0
|
L
 8.8%
H
124.9
200.4
|
L
 -50.7%
H
122
335.2
|
L
 -77.6%
H
122
713.3
|
L
 60.7%
H
83.3
737.5
|
| Angiodynamic Inc |
|
635.4
|
15.1
|
L
 -0.1%
H
15
15.4
|
L
 -2.5%
H
14.9
15.8
|
L
 -0.6%
H
14.9
15.9
|
L
 15.4%
H
12.3
16.3
|
L
 29.8%
H
9.4
16.3
|
L
 104.2%
H
5.3
16.3
|
L
 -42.3%
H
5.3
32
|
L
 -12.7%
H
5.3
32
|
| Anika Therapeutics Inc |
|
255.6
|
19.1
|
L
 -1.3%
H
19.0
19.5
|
L
 -6.2%
H
19.0
20.9
|
L
 -8.2%
H
19.0
21.4
|
L
 24.4%
H
14.6
22.9
|
L
 110.6%
H
8.7
22.9
|
L
 1.8%
H
7.9
29.1
|
L
 -52.5%
H
7.9
45.8
|
L
 -59.1%
H
7.9
75.7
|
| Anzu Special Acq Corp I (Class A) |
|
-
|
0.7
|
L
 3.0%
H
0.7
0.7
|
L
 -5.6%
H
0.7
0.7
|
L
 -4.2%
H
0.7
0.8
|
L
 -9.3%
H
0.6
0.8
|
L
 -16.1%
H
0.4
1.9
|
L
 -59.5%
H
0.4
1.9
|
L
 -93.0%
H
0.4
11.7
|
L
H
0.4
11.7
|
| Apyx Medical Corp |
|
107.4
|
2.6
|
L
 2%
H
2.5
2.6
|
L
 -13.9%
H
2.3
3.0
|
L
 -16.4%
H
2.3
3.1
|
L
 -40.7%
H
2.3
4.5
|
L
 6.7%
H
2.3
5.1
|
L
 -19.0%
H
0.8
5.1
|
L
 -80.6%
H
0.8
17.5
|
L
 -51.9%
H
0.8
17.5
|
| Accuray Inc |
|
33.4
|
0.3
|
L
 3.7%
H
0.3
0.3
|
L
 27.3%
H
0.2
0.4
|
L
 3.7%
H
0.2
0.4
|
L
 7.7%
H
0.2
0.4
|
L
 -83.4%
H
0.2
2.1
|
L
 -90.3%
H
0.2
3.1
|
L
 -93.1%
H
0.2
5.9
|
L
 -95.2%
H
0.2
6.2
|
| Alphatec Holdings Inc |
|
1,549.1
|
10.0
|
L
 1.3%
H
9.8
10.2
|
L
 -0.9%
H
9.8
10.5
|
L
 6.1%
H
8.6
11.0
|
L
 12.4%
H
8.0
11.0
|
L
 -28.2%
H
6.8
23.3
|
L
 -10.8%
H
4.9
23.3
|
L
 -15.5%
H
4.9
23.3
|
L
 36.1%
H
1.2
23.3
|
| Atricure Inc |
|
2,804.8
|
55.1
|
L
 2.9%
H
52
55.3
|
L
 -5.6%
H
52
59.1
|
L
 7.0%
H
51.7
61.7
|
L
 73.5%
H
31.6
61.7
|
L
 58.4%
H
25.4
61.7
|
L
 34.3%
H
18.9
61.7
|
L
 -18.0%
H
18.9
89.2
|
L
 247.9%
H
14.8
89.2
|
| Axogen Inc |
|
2,193.7
|
37.4
|
L
 -6.3%
H
37.0
39.9
|
L
 -13.8%
H
37.0
43.9
|
L
 -22.6%
H
37.0
48.1
|
L
 -18.5%
H
37.0
52.9
|
L
 109.1%
H
15.3
52.9
|
L
 679.0%
H
3.5
52.9
|
L
 149.8%
H
3.5
52.9
|
L
 334.8%
H
3.5
56.9
|
| Bone Biologics Corp |
|
1.3
|
0.5
|
L
H
0.5
0.5
|
L
 -4%
H
0.5
0.5
|
L
 -15.8%
H
0.4
0.6
|
L
 -66.2%
H
0.4
1.5
|
L
 -80.8%
H
0.4
2.8
|
L
 -98.3%
H
0.4
63.4
|
L
 -100.0%
H
0.4
10255.5
|
L
 -100.0%
H
0.4
169920
|
| BioAffinity Tech Inc |
|
3.6
|
6.1
|
L
 -1.3%
H
5.9
6.2
|
L
 -23.6%
H
5.9
8
|
L
 -60.3%
H
5.1
12.5
|
L
 -51.3%
H
4.6
20.4
|
L
 -84.5%
H
4.6
80.7
|
L
 -99.0%
H
4.6
1629
|
L
H
4.6
6997.5
|
L
H
4.6
6997.5
|
| Bluejay Diagnostics Inc |
|
0.9
|
0.8
|
L
 -1.2%
H
0.8
0.9
|
L
 -8.7%
H
0.8
1.0
|
L
 1.2%
H
0.8
1.1
|
L
 -26.3%
H
0.8
2.1
|
L
 -86.4%
H
0.8
16.7
|
L
 -100.0%
H
0.8
7792
|
L
H
0.8
200000
|
L
H
0.8
200000
|
| Biolife Soln Inc |
|
1,824.8
|
37.3
|
L
 1.4%
H
36.8
38.0
|
L
 -3.1%
H
36.7
39.8
|
L
 5.8%
H
34.4
39.8
|
L
 32.7%
H
27.0
39.8
|
L
 40.3%
H
17.9
39.8
|
L
 174.5%
H
8.9
39.8
|
L
 -8.0%
H
8.9
58.8
|
L
 2043.7%
H
1.4
60.7
|
| Biomerica Inc |
|
9.8
|
2.1
|
L
 -4.5%
H
2.1
2.2
|
L
 -7.8%
H
2.1
2.4
|
L
 -7.4%
H
2.0
2.8
|
L
 22.3%
H
1.5
2.8
|
L
 -23.6%
H
1.5
3.2
|
L
 174.4%
H
0.2
4.9
|
L
 -62.0%
H
0.2
7.4
|
L
 -21.6%
H
0.2
23.4
|
| Bruker Corp |
|
9,635.2
|
63.2
|
L
 2.1%
H
62.3
64.4
|
L
 -1.5%
H
61.7
67.0
|
L
 8.1%
H
51.5
67.0
|
L
 2.6%
H
48.6
67.0
|
L
 71.0%
H
32.4
67.0
|
L
 0.7%
H
28.5
94.9
|
L
 -17.8%
H
28.5
94.9
|
L
 185.0%
H
19.6
94.9
|
| BioRestorative Therapies Inc |
|
3.0
|
2.1
|
L
 -5.7%
H
2.1
2.4
|
L
 -16.1%
H
2.1
2.5
|
L
 -27.7%
H
2.1
3.2
|
L
 -73.3%
H
2.1
8.2
|
L
 -92.9%
H
2.1
34.6
|
L
 -94.7%
H
2.1
73.4
|
L
 -99.1%
H
2.1
533.3
|
L
 -100.0%
H
2.1
400800
|
| Bioventus Inc (Class A) |
|
896.8
|
13.1
|
L
 -2.4%
H
13.0
13.5
|
L
 -4.9%
H
13.0
14.2
|
L
 -6.7%
H
12.3
14.2
|
L
 25.3%
H
10.5
15.9
|
L
 87.0%
H
6.4
15.9
|
L
 326.3%
H
2.9
15.9
|
L
 -7.0%
H
0.8
17.5
|
L
H
0.8
19.9
|
| Brainsway Ltd (ADR) |
|
503.2
|
12.5
|
L
 -0.8%
H
12.4
13.0
|
L
 -6.1%
H
12.4
14.0
|
L
 -11.7%
H
12.4
14.5
|
L
 -17.7%
H
12.4
17.4
|
L
 226.4%
H
3.6
17.4
|
L
 1150%
H
0.8
17.4
|
L
 525%
H
0.3
17.4
|
L
H
0.3
17.4
|
| Cardio Diagnostics Holdings Inc |
|
5.8
|
2.0
|
L
 2.1%
H
1.9
2.0
|
L
 0.5%
H
1.9
2.0
|
L
 5.4%
H
1.9
2.2
|
L
 -1.5%
H
1.4
2.3
|
L
 -56.9%
H
1.0
7.9
|
L
 -78.6%
H
1.0
106.8
|
L
H
1.0
307.5
|
L
H
1.0
307.5
|
| Caredx Inc |
|
3,474.0
|
67.2
|
L
 1.4%
H
65.9
69.8
|
L
 5.5%
H
62.3
69.8
|
L
 32.0%
H
48.6
69.8
|
L
 130.0%
H
27.3
69.8
|
L
 342.1%
H
14.0
69.8
|
L
 900.7%
H
4.8
69.8
|
L
 6.0%
H
4.8
75.9
|
L
 1781.0%
H
0.8
99.8
|
| Celcuity Inc |
|
3,528.0
|
72.1
|
L
 -4.0%
H
70.7
75.4
|
L
 -9.3%
H
70.7
88.7
|
L
 -24.7%
H
70.7
97.4
|
L
 -33.2%
H
70.7
117.2
|
L
 42.7%
H
45.0
151.0
|
L
 702.0%
H
7.6
151.0
|
L
 318.2%
H
4.8
151.0
|
L
H
4.0
151.0
|
| Creative Medical Tech Holdings Inc |
|
7.2
|
1.0
|
L
 1.1%
H
0.9
1.0
|
L
 -7.8%
H
0.9
1.0
|
L
 -14.4%
H
0.8
1.1
|
L
 -21.5%
H
0.6
1.9
|
L
 -70.7%
H
0.6
6.3
|
L
 -80.4%
H
0.6
10.3
|
L
 -98.8%
H
0.6
95
|
L
 -100.0%
H
0.6
525000
|
| Cerus Corp |
|
459.5
|
2.3
|
L
 -1.7%
H
2.3
2.4
|
L
 -13.0%
H
2.3
2.6
|
L
 -12.0%
H
2.3
2.7
|
L
 -27.9%
H
2.1
3.5
|
L
 45.2%
H
1.4
3.5
|
L
 49.0%
H
1.1
3.5
|
L
 -61.8%
H
1.1
8.1
|
L
 -63.2%
H
1.1
8.9
|
| Check-Cap Ltd |
|
50.3
|
3.3
|
L
 4.1%
H
3.0
3.3
|
L
 -28.3%
H
3.0
4.6
|
L
 -49.4%
H
3.0
6.8
|
L
 -58.8%
H
1.2
10.5
|
L
 -79.3%
H
1.2
27.4
|
L
 -86.4%
H
1.2
27.6
|
L
 -97.2%
H
1.2
183.4
|
L
 -99.9%
H
1.2
4956
|
| CollPlant biotech Ltd - Ordinary Shares New |
|
5.0
|
3.5
|
L
 -3.1%
H
3.3
3.6
|
L
 -18.6%
H
3.3
4.3
|
L
 -2.5%
H
3.3
4.8
|
L
 1.8%
H
2.6
9.6
|
L
 -85.6%
H
2.6
26.8
|
L
 -94.1%
H
2.6
69.9
|
L
 -97.8%
H
2.6
230
|
L
 -98.1%
H
2.6
242.6
|
| ClearPoint Neuro Inc |
|
332.5
|
10.9
|
L
 -4.8%
H
10.9
11.6
|
L
 -26.5%
H
10.9
15.4
|
L
 -21.9%
H
10.9
16.5
|
L
 -41.8%
H
10.9
18.9
|
L
 -60.2%
H
8.3
30.1
|
L
 132.9%
H
4.1
30.1
|
L
 -35.9%
H
4.1
30.1
|
L
 80.2%
H
1.3
31.3
|
| Cardiff Oncology Inc |
|
87.1
|
1.1
|
L
 -5.1%
H
1.1
1.2
|
L
 -9.7%
H
1.1
1.2
|
L
 2.8%
H
1.0
1.5
|
L
 -11.8%
H
0.8
1.5
|
L
 -48.9%
H
0.8
3.3
|
L
 -5.1%
H
0.8
6.4
|
L
 -83.6%
H
0.8
7.3
|
L
 -99.7%
H
0.7
342
|
| Castle Biosciences Inc |
|
1,086.3
|
35.6
|
L
 0.9%
H
34.8
35.9
|
L
 -0.7%
H
34.1
37.0
|
L
 8.1%
H
31.4
37.0
|
L
 47.5%
H
22.5
37.0
|
L
 56.5%
H
17.7
44.3
|
L
 130.8%
H
12.1
44.3
|
L
 -41.2%
H
9.3
68.7
|
L
H
9.3
107.7
|
| Cytek BioSciences Inc |
|
763.0
|
5.9
|
L
 1.0%
H
5.8
5.9
|
L
 3.9%
H
5.5
6.0
|
L
 24.9%
H
4.5
6.0
|
L
 27.9%
H
4.0
6.0
|
L
 47.9%
H
3.3
6.2
|
L
 8.1%
H
2.4
9.9
|
L
 -73.3%
H
2.4
26.5
|
L
H
2.4
28.7
|
| Cytosorbents Corp |
|
12.8
|
4.1
|
L
 -3.1%
H
3.8
4.3
|
L
 -7.5%
H
3.8
4.6
|
L
 -42.1%
H
3.8
7.4
|
L
 -48.1%
H
3.8
9.4
|
L
 -79.4%
H
3.8
20
|
L
 -88.0%
H
3.8
42.8
|
L
 -97.5%
H
3.8
161.9
|
L
 -97.0%
H
3.8
299
|
| Citius Pharma Inc |
|
14.5
|
0.5
|
L
 -1.9%
H
0.5
0.6
|
L
 -8.6%
H
0.5
0.6
|
L
 -10.2%
H
0.5
0.6
|
L
 -8.6%
H
0.5
0.8
|
L
 -61.3%
H
0.5
2.2
|
L
 -96.9%
H
0.1
26.8
|
L
 -98.9%
H
0.1
56.3
|
L
 -99.8%
H
0.1
371.3
|
| CVRx Inc |
|
41.3
|
1.6
|
L
 1.3%
H
1.5
1.7
|
L
 -42.6%
H
1.5
2.8
|
L
 -49.2%
H
1.5
3.1
|
L
 -72.3%
H
1.5
6
|
L
 -82.2%
H
1.5
11.3
|
L
 -89.5%
H
1.5
33.1
|
L
 -90.4%
H
1.5
33.1
|
L
H
1.5
33.1
|
| Delcath Systems Inc |
|
525.0
|
15.1
|
L
 -1.8%
H
15.1
15.6
|
L
 -3.0%
H
15.1
16.0
|
L
 -8.2%
H
15.1
16.5
|
L
 14.6%
H
11.5
17.4
|
L
 36.3%
H
8.1
17.4
|
L
 311.1%
H
2.3
18.2
|
L
 57.9%
H
2.3
18.2
|
L
 -100.0%
H
2.3
400575000
|
| DarioHealth Corp |
|
63.3
|
6.5
|
L
 4.9%
H
6.1
6.6
|
L
 -2.6%
H
6.1
6.9
|
L
 -10.8%
H
6.1
7.3
|
L
 -11.3%
H
6.1
8.2
|
L
 -60.5%
H
5.8
16.6
|
L
 -90.2%
H
5.8
67.4
|
L
 -97.4%
H
5.8
387.8
|
L
 -99.6%
H
5.8
1880
|
| Alpha Tau Medical Ltd |
|
1,365.9
|
14.8
|
L
 1.8%
H
14.6
14.9
|
L
 1.6%
H
14.3
15.3
|
L
 -1.7%
H
13.8
15.8
|
L
 11.6%
H
11.0
15.8
|
L
 242.7%
H
3.4
15.8
|
L
 322%
H
1.8
15.8
|
L
H
1.8
20.7
|
L
H
1.8
20.7
|
| DexCom |
|
32,211.5
|
85.4
|
L
 -1.0%
H
84.8
86.7
|
L
 -1.5%
H
84.8
87.7
|
L
 -2.9%
H
82.3
90.4
|
L
 19.8%
H
69.7
92.6
|
L
 27.3%
H
54.1
92.6
|
L
 -2.7%
H
54.1
142
|
L
 -35.1%
H
54.1
164.9
|
L
 316.8%
H
10.7
164.9
|
| ElectroCore Inc |
|
91.4
|
10.1
|
L
 -1.7%
H
9.9
11.0
|
L
 -8.8%
H
9.9
11.3
|
L
 10.1%
H
8.7
12.7
|
L
 15.6%
H
5.6
12.7
|
L
 102.4%
H
4.4
12.7
|
L
 60.4%
H
4.2
19.5
|
L
 -38.0%
H
2.9
19.5
|
L
H
2.9
303.8
|
| ChronoScale Corp |
|
2,797.7
|
19.2
|
L
 -0.8%
H
19.1
20.9
|
L
 -3.2%
H
18.8
20.9
|
L
 -5.2%
H
17.8
22.6
|
L
 16.5%
H
16.3
30
|
L
 243.0%
H
3.5
30
|
L
 -87.8%
H
2.7
704.0
|
L
 -98.1%
H
2.7
1010.3
|
L
 -99.9%
H
2.7
21532.5
|
| Embecta Corp |
|
320.1
|
5.7
|
L
 -2.4%
H
5.5
5.8
|
L
 -4.2%
H
5.5
6.0
|
L
 -2.6%
H
4.9
6.0
|
L
 68.7%
H
3.1
6.0
|
L
 -60.5%
H
2.8
14.9
|
L
 -57.5%
H
2.8
21.5
|
L
H
2.8
63
|
L
H
2.8
63
|
| Establishment Labs Holdings Inc |
|
1,909.1
|
64.1
|
L
 1.6%
H
62.4
65.3
|
L
 -2.9%
H
61.9
66.2
|
L
 -13.8%
H
61.9
75.8
|
L
 -28.2%
H
61.9
97.6
|
L
 54.6%
H
38.4
97.6
|
L
 56.0%
H
17
97.6
|
L
 -7.6%
H
17
97.6
|
L
H
7.6
97.6
|
| EDAP TMS S.A. (ADR) |
|
157.4
|
4.2
|
L
 -2.8%
H
4.2
4.4
|
L
 -10.8%
H
4.2
4.8
|
L
 1.2%
H
4
4.8
|
L
 -18.9%
H
4
6.4
|
L
 81.0%
H
1.8
6.4
|
L
 -40.4%
H
1.2
8.5
|
L
 -30.8%
H
1.2
12.7
|
L
 45.8%
H
1.2
12.7
|
| GlucoTrack Inc |
|
1.2
|
1.2
|
L
 -14.2%
H
1.2
1.3
|
L
 -33.5%
H
1.2
2.0
|
L
 -59.4%
H
1.2
3.3
|
L
 -74.8%
H
1.2
13.5
|
L
 -98.9%
H
1.2
136.3
|
L
 -100.0%
H
1.2
89100
|
L
 -100.0%
H
1.2
495000
|
L
 -100.0%
H
1.2
7020000
|
| GE HealthCare Tech |
|
29,038.9
|
64.3
|
L
 0.5%
H
64.0
65.0
|
L
 -3.5%
H
63.9
67.1
|
L
 -6.6%
H
63
68.1
|
L
 -1.9%
H
60.2
75.7
|
L
 -16.0%
H
58.8
89.8
|
L
 -5.3%
H
57.7
94.8
|
L
H
53
94.8
|
L
H
53
94.8
|
| Guardant Health Inc |
|
23,860.1
|
177.8
|
L
 1.8%
H
172
179.2
|
L
 0.3%
H
172
180.9
|
L
 10.2%
H
155.8
183.5
|
L
 5.9%
H
140.9
183.5
|
L
 182.9%
H
61
183.5
|
L
 530.5%
H
15.8
183.5
|
L
 67.8%
H
15.8
183.5
|
L
H
15.8
183.5
|
| Harvard Bioscience Inc |
|
38.0
|
8.3
|
L
 2.6%
H
8.0
8.4
|
L
 4.8%
H
7.9
8.4
|
L
 4.0%
H
7.9
8.4
|
L
 35.6%
H
5.9
8.4
|
L
 85.8%
H
3.8
9.4
|
L
 -80.6%
H
2.8
55.6
|
L
 -87.6%
H
2.8
82.3
|
L
 -68.2%
H
2.8
87.5
|
| Cue Health Inc |
|
4,721.8
|
29.7
|
L
 0.6%
H
29.4
29.9
|
L
 0.3%
H
29.4
30.5
|
L
 4.1%
H
27.3
30.5
|
L
H
24.9
31.2
|
L
H
24.9
31.2
|
L
 6966.7%
H
0
31.2
|
L
 195.0%
H
0
31.2
|
L
H
0
31.2
|
| Heart Test Laboratories Inc |
|
20.8
|
4.3
|
L
 10.5%
H
3.9
4.4
|
L
 -9.1%
H
3.8
4.7
|
L
 15.3%
H
3.3
5.3
|
L
 54.1%
H
1.9
5.3
|
L
 16.2%
H
1.6
5.3
|
L
 -89.8%
H
1.6
52
|
L
H
1.6
600
|
L
H
1.6
600
|
| Helius Medical Tech Inc (Class A) |
|
171.2
|
2.6
|
L
 0.4%
H
2.6
2.9
|
L
 -10.5%
H
2.3
3.0
|
L
 17.4%
H
2.1
3.4
|
L
 46.9%
H
1.6
3.4
|
L
 -83.8%
H
1.2
20.5
|
L
 -100.0%
H
1.2
7125
|
L
 -100.0%
H
1.2
555015
|
L
 -100.0%
H
1.2
27168750
|
| Hyperfine Inc (Class A) |
|
94.4
|
0.9
|
L
 2.3%
H
0.8
0.9
|
L
 9.9%
H
0.8
0.9
|
L
 9.9%
H
0.8
0.9
|
L
 -31.5%
H
0.8
1.3
|
L
 -39.9%
H
0.8
2.2
|
L
 -51.4%
H
0.5
2.2
|
L
 -91.0%
H
0.5
16.6
|
L
H
0.5
16.6
|
| Integra Lifesciences Holdings Corp |
|
986.2
|
12.7
|
L
 -21.2%
H
12.6
14
|
L
 -21.3%
H
12.6
16.8
|
L
 -24.2%
H
12.6
16.8
|
L
 -29.8%
H
12.6
20.5
|
L
 -14.3%
H
8.7
20.5
|
L
 -66.2%
H
8.7
45.4
|
L
 -81.2%
H
8.7
75.0
|
L
 -69.3%
H
8.7
77.4
|
| Icecure Medical Ltd |
|
7.3
|
1.6
|
L
 -7.1%
H
1.6
1.8
|
L
 -9.3%
H
1.6
1.8
|
L
 -29.6%
H
1.6
2.5
|
L
 -70.7%
H
1.6
5.1
|
L
 -94.6%
H
1.6
33
|
L
 -93.7%
H
1.6
49.8
|
L
 -99.3%
H
1.6
249.3
|
L
 -95.5%
H
1.6
480
|
| SeaStar Medical Holding Corp |
|
20.7
|
4.7
|
L
 25.1%
H
3.7
4.8
|
L
 37.1%
H
3.3
4.8
|
L
 57.4%
H
2.9
4.8
|
L
 -4.7%
H
2.8
5.4
|
L
 -92.8%
H
2.1
73.5
|
L
 -99.7%
H
2.1
4292.3
|
L
 -100.0%
H
2.1
55000
|
L
H
2.1
55000
|
| ICU Medical Inc |
|
3,985.6
|
159.4
|
L
 1.4%
H
157.2
161.3
|
L
 -3.4%
H
156.9
166.7
|
L
 -4.9%
H
151.3
167.7
|
L
 2.9%
H
150.9
192.9
|
L
 30.6%
H
112.5
192.9
|
L
 34.5%
H
78.4
196.3
|
L
 -31.7%
H
78.4
251.8
|
L
 26.8%
H
78.4
321.7
|
| Idexx Laboratories |
|
40,839.3
|
518.4
|
L
 0.1%
H
516.0
524.0
|
L
 -0.2%
H
515.1
536.8
|
L
 -3.2%
H
500.6
536.8
|
L
 -7.1%
H
500.6
624.2
|
L
 -17.9%
H
500.6
770.0
|
L
 19.7%
H
356.3
770.0
|
L
 -15.6%
H
317.1
770.0
|
L
 359.0%
H
102.5
770.0
|
| QTREX Quantum |
|
60.9
|
1.1
|
L
 41.0%
H
0.9
1.3
|
L
 41.0%
H
0.6
1.3
|
L
 32.5%
H
0.6
1.3
|
L
 -23.1%
H
0.6
1.8
|
L
 -8.3%
H
0.3
3.9
|
L
 -20.9%
H
0.3
3.9
|
L
 -59.9%
H
0.3
9.6
|
L
H
0.3
9.6
|
| Illumina Inc |
|
41,229.0
|
273.0
|
L
 2.8%
H
265.4
275.0
|
L
 1.1%
H
262.9
280.2
|
L
 25.1%
H
200.0
280.2
|
L
 44.7%
H
178.9
280.2
|
L
 167.4%
H
88
280.2
|
L
 97.4%
H
68.7
280.2
|
L
 -28.1%
H
68.7
428
|
L
 50.7%
H
68.7
555.8
|
| Intercure Ltd |
|
81.3
|
5.4
|
L
 0.9%
H
5.4
5.4
|
L
 4.0%
H
5.0
5.5
|
L
H
5.0
5.7
|
L
 -0.6%
H
4.2
6.1
|
L
 -33.1%
H
3.4
8.5
|
L
 -31.4%
H
3.4
18.6
|
L
 -83.8%
H
3.4
43.9
|
L
H
3.4
96.8
|
| Inogen Inc |
|
158.4
|
6.0
|
L
 -0.2%
H
5.8
6.1
|
L
 11.4%
H
5.3
6.2
|
L
 10.2%
H
5.0
6.2
|
L
 -9.6%
H
5.0
6.9
|
L
 -31.0%
H
5.0
9.1
|
L
 20.9%
H
4.1
13.3
|
L
 -86.1%
H
4.1
44.3
|
L
 -90.0%
H
4.1
287.8
|
| Inmode Ltd |
|
810.8
|
14.1
|
L
 0.3%
H
14.0
14.2
|
L
 -1.2%
H
14.0
14.3
|
L
 -5.5%
H
14.0
15.0
|
L
 -4.8%
H
14.0
15.7
|
L
 -7%
H
12.7
16.7
|
L
 -50.1%
H
12.7
29.3
|
L
 -79.5%
H
12.7
99.3
|
L
H
6.5
99.3
|
| NAYA Biosciences |
|
2.2
|
0.9
|
L
 -4.4%
H
0.8
0.9
|
L
 -8.5%
H
0.8
1.0
|
L
 -12.2%
H
0.8
1.0
|
L
 -46.9%
H
0.8
2.8
|
L
 -97.3%
H
0.8
84.4
|
L
 -99.9%
H
0.8
5040
|
L
 -100.0%
H
0.8
123264
|
L
 -100.0%
H
0.8
709632
|
| IRIDEX Corp |
|
11.2
|
0.6
|
L
 1.6%
H
0.6
0.6
|
L
 3.2%
H
0.6
0.7
|
L
 -8.6%
H
0.6
0.7
|
L
 -43.4%
H
0.6
1.2
|
L
 -46.7%
H
0.6
1.7
|
L
 -78.2%
H
0.6
3.7
|
L
 -91.5%
H
0.6
9.5
|
L
 -95.6%
H
0.6
16.4
|
| Iradimed Corp |
|
1,092.0
|
85.4
|
L
 0.1%
H
84.5
86.3
|
L
 -0.4%
H
84.5
87.7
|
L
 2.3%
H
81.4
87.9
|
L
 -15.4%
H
81.4
103.0
|
L
 19.9%
H
70.8
107.9
|
L
 100.0%
H
36.1
107.9
|
L
 160.4%
H
26
107.9
|
L
 692.9%
H
7.9
107.9
|
| iRhythm Tech Inc |
|
3,638.1
|
110.4
|
L
 -0.6%
H
109.3
112.1
|
L
 0.0%
H
109.2
114.8
|
L
 -10.3%
H
107.9
124.9
|
L
 -12.7%
H
105.3
136.7
|
L
 -37.2%
H
100.9
212
|
L
 28.1%
H
55.9
212
|
L
 89.2%
H
55.9
212
|
L
H
22.2
286.2
|
| Intuitive Surgical |
|
140,427.1
|
392.0
|
L
 -2.3%
H
391.4
406.5
|
L
 -3.3%
H
391.4
416.5
|
L
 6.9%
H
345.3
416.5
|
L
 -8%
H
328.6
443.8
|
L
 -13.4%
H
328.6
603.9
|
L
 35.0%
H
254.9
616
|
L
 21.2%
H
180.1
616
|
L
 392.3%
H
67.9
616
|
| Kewaunee Scientific Corp |
|
98.9
|
34.2
|
L
 0.7%
H
34.2
34.3
|
L
 0.4%
H
33.8
34.5
|
L
 -7.7%
H
32
37.7
|
L
 -6.9%
H
32
39
|
L
 -20.3%
H
32
46.6
|
L
 96.5%
H
16.5
71.3
|
L
 164.6%
H
12.1
71.3
|
L
 51.4%
H
7.0
71.3
|
| OrthoPediatrics corp |
|
578.6
|
22.2
|
L
 2.2%
H
21.5
22.3
|
L
 -1.7%
H
21.5
23.1
|
L
 -1.1%
H
21
23.5
|
L
 11.1%
H
18.1
26.7
|
L
 18.1%
H
14.4
26.7
|
L
 -26.3%
H
14.4
36.1
|
L
 -64.4%
H
14.4
73.9
|
L
H
14
73.9
|
| KORU Medical Systems Inc |
|
136.7
|
3.0
|
L
 -2.0%
H
2.9
3.3
|
L
 -7.8%
H
2.9
3.3
|
L
 -8.9%
H
2.9
3.4
|
L
 -34.1%
H
2.9
4.7
|
L
 -23.1%
H
2.9
6.6
|
L
 10.4%
H
1.9
6.6
|
L
 2.4%
H
1.8
6.6
|
L
 572.7%
H
0.3
12.8
|
| Standard BioTools Inc |
|
290.5
|
0.7
|
L
 1.4%
H
0.7
0.8
|
L
H
0.7
0.8
|
L
 7.3%
H
0.7
0.8
|
L
 -18.7%
H
0.6
1.0
|
L
 -44.8%
H
0.6
1.7
|
L
 -64.8%
H
0.6
3.0
|
L
 -87.4%
H
0.6
6.0
|
L
 -90.7%
H
0.6
14.9
|
| LivaNova PLC |
|
4,135.9
|
75.1
|
L
 0.5%
H
74.6
76.8
|
L
 -2.0%
H
74.5
77.7
|
L
 -8.4%
H
74.1
81.8
|
L
 -10.2%
H
74.1
85.8
|
L
 40.7%
H
48.8
85.8
|
L
 45.4%
H
32.5
85.8
|
L
 -6.2%
H
32.5
93.9
|
L
 24.6%
H
32.5
131.5
|
| Lemaitre Vascular Inc |
|
1,805.8
|
79.0
|
L
 -1.5%
H
78.7
81.4
|
L
 -3.1%
H
78.7
83.3
|
L
 -2.1%
H
78.2
83.3
|
L
 -23.3%
H
78.2
106.3
|
L
 -10.1%
H
78.2
118.0
|
L
 43.7%
H
44.3
118.0
|
L
 49.5%
H
38.3
118.0
|
L
 298.0%
H
18.6
118.0
|
| LENSAR Inc |
|
82.9
|
6.8
|
L
 2.7%
H
6.6
6.9
|
L
 -2.5%
H
6.5
7.0
|
L
 -21.3%
H
6.5
8.7
|
L
 5.5%
H
5.0
9.3
|
L
 -44.6%
H
5.0
12.9
|
L
 139.4%
H
1.8
17.3
|
L
 -11.2%
H
1.8
17.3
|
L
H
1.8
17.3
|
| Lantheus Holdings Inc |
|
6,527.4
|
100.0
|
L
 0.3%
H
99.7
100.1
|
L
 0.2%
H
99.3
100.1
|
L
 -1%
H
99.3
101.1
|
L
 -9.0%
H
98.8
110.6
|
L
 85.7%
H
49.7
111.9
|
L
 38.0%
H
47.3
126.9
|
L
 303.9%
H
22.2
126.9
|
L
 1091.4%
H
7.6
126.9
|
| Lucid Diagnostics Inc |
|
120.3
|
0.6
|
L
 -1.6%
H
0.6
0.7
|
L
 -24.1%
H
0.5
0.8
|
L
 -33.0%
H
0.5
0.9
|
L
 -41.1%
H
0.5
1.2
|
L
 -39.4%
H
0.5
1.6
|
L
 -50.8%
H
0.5
1.8
|
L
H
0.5
13.5
|
L
H
0.5
13.5
|
| Pulmonx Corp |
|
78.6
|
1.8
|
L
 -4.2%
H
1.8
1.9
|
L
 -4.2%
H
1.8
2
|
L
 -17.2%
H
1.8
2.2
|
L
 31.7%
H
1.2
2.6
|
L
 -0.5%
H
1.1
2.9
|
L
 -81.1%
H
1.1
14.8
|
L
 -95.1%
H
1.1
45.5
|
L
H
1.1
69.5
|
| 908 Devices Inc |
|
524.5
|
12.7
|
L
 1.4%
H
12.5
12.9
|
L
 10.9%
H
11.1
12.9
|
L
 26.3%
H
9.3
12.9
|
L
 46.0%
H
6.9
12.9
|
L
 39.9%
H
5.0
12.9
|
L
 103.0%
H
1.8
12.9
|
L
 -62.3%
H
1.8
39.3
|
L
H
1.8
79.6
|
| Mimedx Grp Inc |
|
669.8
|
4.6
|
L
 -1.1%
H
4.5
4.7
|
L
 -1.7%
H
4.5
4.7
|
L
 0.4%
H
4.4
5.0
|
L
 16.2%
H
3.8
5.0
|
L
 -36.3%
H
3.0
8.0
|
L
 -37.2%
H
3.0
10.1
|
L
 -19.5%
H
2.4
10.1
|
L
 -47.7%
H
1.0
18.3
|
| Mesa Laboratories Inc |
|
741.7
|
132.6
|
L
 2.5%
H
130.1
134.4
|
L
 -1.1%
H
129.0
135.0
|
L
 3.7%
H
119.1
138.7
|
L
 25.6%
H
90
138.7
|
L
 80.9%
H
66.6
138.7
|
L
 34.0%
H
55.5
155.1
|
L
 -55.7%
H
55.5
333.4
|
L
 13.7%
H
55.5
333.4
|
| Merit Medical Systems Inc |
|
5,097.5
|
85.4
|
L
 -0.9%
H
85.2
86.9
|
L
 -2.4%
H
85.2
88.2
|
L
 -4.7%
H
84.1
88.9
|
L
 20.1%
H
70
92.3
|
L
 1.4%
H
59.7
94.8
|
L
 27.7%
H
59.7
111.5
|
L
 21.1%
H
50.5
111.5
|
L
 248.0%
H
19.5
111.5
|
| Modular Medical Inc |
|
19.3
|
2.0
|
L
 -2.4%
H
2.0
2.3
|
L
 -3.8%
H
1.8
2.3
|
L
 -44.8%
H
1.8
3.6
|
L
 -55.9%
H
1.7
4.9
|
L
 -90.1%
H
1.7
21.2
|
L
 -93.6%
H
1.7
79.5
|
L
 -99.3%
H
1.7
450
|
L
 -91.6%
H
1.7
585.0
|
| MedTech Acq Corp (Class A) |
|
-
|
4.3
|
L
 4.1%
H
4.0
4.5
|
L
 -0.5%
H
4.0
4.5
|
L
 -13.6%
H
4.0
5.8
|
L
 -7.9%
H
3.7
5.9
|
L
 -6.5%
H
2.2
8.0
|
L
 -16.0%
H
2.2
8.0
|
L
 -56.3%
H
2.2
12.8
|
L
H
2.2
12.8
|
| Myriad Genetics Inc |
|
434.2
|
4.5
|
L
 11.8%
H
4.2
4.6
|
L
 8.9%
H
4.1
4.6
|
L
 42.3%
H
3.1
4.6
|
L
 -24.2%
H
2.7
6.4
|
L
 -43.7%
H
2.7
8.6
|
L
 -71.0%
H
2.7
29.3
|
L
 -85.3%
H
2.7
33.1
|
L
 -77.9%
H
2.7
50.4
|
| MDxHealth SA (ADR) |
|
-
|
0.6
|
L
 -1.7%
H
0.6
0.6
|
L
 1.8%
H
0.5
0.6
|
L
 -24%
H
0.5
0.8
|
L
 18.8%
H
0.4
1.1
|
L
 -88.2%
H
0.4
5.3
|
L
 -74.1%
H
0.4
5.3
|
L
H
0.4
13.2
|
L
H
0.4
13.2
|
| ENDRA Life Sciences Inc |
|
9.1
|
6.1
|
L
 3.1%
H
5.9
6.1
|
L
 0.3%
H
5.7
6.4
|
L
 0.2%
H
4.9
6.7
|
L
 28.4%
H
4.1
6.8
|
L
 5.4%
H
3.0
9.9
|
L
 -88.2%
H
0.0
139.5
|
L
 -99.6%
H
0.0
1750
|
L
H
0.0
5880
|
| Neogen Corp |
|
2,650.0
|
12.2
|
L
 -0.7%
H
12.1
12.5
|
L
 -11.7%
H
12.1
13.9
|
L
 2.7%
H
11.6
14.3
|
L
 30.1%
H
9.1
14.3
|
L
 100.5%
H
5.4
14.3
|
L
 -30.5%
H
3.9
20.9
|
L
 -72.3%
H
3.9
47.8
|
L
 -41.5%
H
3.9
48.9
|
| Nephros Inc |
|
39.9
|
3.7
|
L
H
3.6
3.9
|
L
 -13.2%
H
3.5
4.4
|
L
 -9.6%
H
3.5
4.8
|
L
 7.9%
H
3.2
4.9
|
L
 -23.1%
H
2.7
6.4
|
L
 139.9%
H
1.4
6.4
|
L
 -56.6%
H
0.9
8.5
|
L
 23.6%
H
0.9
11.7
|
| NeuroOne Medical Tech Corp |
|
10.2
|
1.1
|
L
 14.3%
H
1.0
1.2
|
L
 -15.8%
H
1.0
1.3
|
L
 -30.9%
H
1.0
1.7
|
L
 -62.7%
H
1.0
3.5
|
L
 -79.9%
H
1.0
7.0
|
L
 -79.7%
H
1.0
12
|
L
 -95.3%
H
1.0
25.4
|
L
H
1.0
180
|
| Nano X Imaging Ltd |
|
50.3
|
0.6
|
L
 -3.0%
H
0.6
0.7
|
L
H
0.6
0.7
|
L
 -22.9%
H
0.6
1.0
|
L
 -50.8%
H
0.6
1.4
|
L
 -83.7%
H
0.6
4.7
|
L
 -90.9%
H
0.6
14.3
|
L
 -97.1%
H
0.6
28.6
|
L
H
0.6
94.8
|
| NeuroPace Inc |
|
435.9
|
12.7
|
L
 -3.4%
H
12.7
13.3
|
L
 -9.7%
H
12.7
14.5
|
L
 -14.8%
H
12.7
15.1
|
L
 -21.3%
H
12.7
18.2
|
L
 16.3%
H
9.2
19.6
|
L
 61.8%
H
5.5
19.6
|
L
 -26.1%
H
1.2
19.6
|
L
H
1.2
27.4
|
| InspireMD Inc |
|
29.0
|
0.6
|
L
H
0.6
0.6
|
L
 -11.4%
H
0.6
0.7
|
L
 -27.1%
H
0.6
0.9
|
L
 -11.4%
H
0.6
1.0
|
L
 -74.1%
H
0.6
2.6
|
L
 -81.8%
H
0.6
3.9
|
L
 -84.6%
H
0.6
4.7
|
L
 -100.0%
H
0.6
115237.5
|
| Nortech Systems Inc |
|
33.0
|
11.6
|
L
 5.7%
H
11.0
11.8
|
L
 2.7%
H
10.9
11.8
|
L
 -1.1%
H
10.9
12.2
|
L
 -20.4%
H
10.9
15.7
|
L
 28.7%
H
6.5
18.0
|
L
 30.8%
H
6.5
19.2
|
L
 -0.6%
H
6.5
19.6
|
L
 211.3%
H
2.5
19.6
|
| Nutriband Inc |
|
88.5
|
7.3
|
L
 -1.1%
H
7.3
7.9
|
L
 -9%
H
7.3
9.0
|
L
 21.9%
H
5.5
9.2
|
L
 137.9%
H
2.8
9.2
|
L
 -2.0%
H
2.8
9.2
|
L
 205.9%
H
1.5
11.8
|
L
 31.2%
H
1.5
11.8
|
L
H
0.9
43.5
|
| Nuwellis Inc |
|
2.2
|
0.7
|
L
 -8%
H
0.7
0.8
|
L
 -11.5%
H
0.7
0.8
|
L
 -11.5%
H
0.7
1.5
|
L
 -78.1%
H
0.7
6.4
|
L
 -80.7%
H
0.1
6.4
|
L
 -100.0%
H
0.1
1984.5
|
L
 -100.0%
H
0.1
364560
|
L
 -100.0%
H
0.1
10000000000
|
| NovoCure Ltd |
|
1,739.7
|
14.9
|
L
 -6.2%
H
14.9
16.2
|
L
 -5.7%
H
14.9
16.4
|
L
 -16.7%
H
14.9
17.8
|
L
 -13.1%
H
14.8
21.5
|
L
 1.9%
H
9.8
21.5
|
L
 1.1%
H
9.8
34.1
|
L
 -86.3%
H
9.8
124.4
|
L
 79.8%
H
6.0
232.8
|
| enVVeno Medical Corp |
|
5.6
|
8.1
|
L
 0.8%
H
7.7
8.8
|
L
 -6.6%
H
7.7
9.4
|
L
 -29.2%
H
7.0
11.8
|
L
 -27.1%
H
7.0
12.5
|
L
 -76.1%
H
7.0
35.2
|
L
 -95.9%
H
7.0
244.0
|
L
 -97.6%
H
7.0
364
|
L
H
7.0
4935
|
| Nexalin Tech Inc |
|
4.8
|
5.7
|
L
 -24.1%
H
5.2
6.0
|
L
 30.5%
H
4.1
11.0
|
L
 13.2%
H
4
11.0
|
L
 -47.1%
H
4
15.5
|
L
 -79.0%
H
4
60
|
L
 -50.9%
H
4
134.7
|
L
H
4
134.7
|
L
H
4
134.7
|
| Nyxoah SA |
|
138.5
|
1.4
|
L
 2.3%
H
1.3
1.4
|
L
 -6.2%
H
1.3
1.7
|
L
 -16.1%
H
1.3
1.7
|
L
 -20.9%
H
1.3
1.9
|
L
 -72.5%
H
1.3
6.9
|
L
 -80.0%
H
1.3
20
|
L
 -95.4%
H
1.3
30.3
|
L
H
1.3
37
|
| Orchestra BioMed Holdings Inc |
|
357.6
|
6.0
|
L
 -6.3%
H
5.8
6.4
|
L
H
5.8
6.5
|
L
 17.1%
H
4.8
6.5
|
L
 42%
H
3.6
6.5
|
L
 119.6%
H
2.7
6.5
|
L
 -31.1%
H
2.2
11.7
|
L
 -39.3%
H
2.2
23.4
|
L
H
2.2
23.4
|
| Orthofix Medical Inc |
|
370.3
|
9.1
|
L
 -1.3%
H
9.1
9.3
|
L
 -3.7%
H
9.1
9.9
|
L
 -2.2%
H
8.5
9.9
|
L
 -8.6%
H
8.5
12.6
|
L
 -37.8%
H
8.5
17.0
|
L
 -26.5%
H
8.5
20.7
|
L
 -76.1%
H
8.5
38.8
|
L
 -78.1%
H
8.5
74.4
|
| Outset Medical Inc |
|
74.4
|
4.0
|
L
 5.6%
H
3.5
4.1
|
L
 29.8%
H
2.8
4.1
|
L
 10.3%
H
2.8
4.1
|
L
 -16.1%
H
2.8
5.3
|
L
 -72.7%
H
2.8
16.2
|
L
 -97.4%
H
0.5
154.5
|
L
 -99.4%
H
0.5
905.0
|
L
H
0.5
1004.4
|
| Organogenesis Holdings Inc (Class A) |
|
171.1
|
1.3
|
L
 -5%
H
1.3
1.4
|
L
 -5.7%
H
1.3
1.4
|
L
 -22.2%
H
1.3
1.7
|
L
 -43.6%
H
1.3
2.7
|
L
 -69%
H
1.3
7.1
|
L
 -53.5%
H
1.3
7.1
|
L
 -89.8%
H
1.3
13.6
|
L
H
1.3
310.9
|
| Orasure Tech Inc |
|
273.1
|
4.0
|
L
 2.1%
H
3.9
4
|
L
 0.8%
H
3.8
4.0
|
L
 13.8%
H
3.1
4.1
|
L
 -9.0%
H
3.1
4.5
|
L
 24.5%
H
2.1
4.6
|
L
 -32.9%
H
2.1
8.5
|
L
 -63.2%
H
2.1
11.6
|
L
 -50.6%
H
2.1
23.0
|
| Pacific Biosciences of California Inc |
|
789.5
|
2.5
|
L
 1.2%
H
2.4
2.6
|
L
 56.8%
H
1.6
2.6
|
L
 88.2%
H
1.3
2.6
|
L
 51.2%
H
1.1
2.6
|
L
 70.5%
H
1.1
2.7
|
L
 -68.3%
H
0.9
10.7
|
L
 -89.6%
H
0.9
31.1
|
L
 -71.2%
H
0.9
53.7
|
| PAVmed Inc |
|
28.2
|
2.9
|
L
 6.3%
H
2.7
3.0
|
L
 -25.3%
H
2.6
4.1
|
L
 -45.6%
H
2.6
5.4
|
L
 -49.7%
H
2.6
6.7
|
L
 -78.1%
H
2.6
28.4
|
L
 -97.6%
H
2.6
150.8
|
L
 -99.9%
H
2.6
4036.5
|
L
 -100.0%
H
2.6
5884.7
|
| Pro-Dex Inc (co) |
|
205.2
|
64.1
|
L
 -2.0%
H
63.7
67.0
|
L
 -10.7%
H
63.7
73
|
L
 -12.7%
H
58.0
74.2
|
L
 4.5%
H
53
77
|
L
 88.3%
H
23.5
77
|
L
 318.8%
H
14.5
77
|
L
 159.7%
H
12.4
77
|
L
 1369.5%
H
3.8
77
|
| Pulse Biosciences Inc |
|
3,416.4
|
47.9
|
L
 -3.9%
H
47.8
50.7
|
L
 -7.2%
H
47.8
53.6
|
L
 -10.0%
H
47.7
58.9
|
L
 64.0%
H
24.9
58.9
|
L
 148.3%
H
12.6
58.9
|
L
 1131.4%
H
3.8
58.9
|
L
 135.6%
H
1.2
58.9
|
L
 659.1%
H
1.2
58.9
|
| Axe Compute Inc |
|
140.0
|
12.1
|
L
 5.8%
H
11.4
12.5
|
L
 -0.1%
H
11.1
13.5
|
L
 13.2%
H
10.5
13.5
|
L
 70.6%
H
6.6
13.5
|
L
 -15.6%
H
1.0
15.1
|
L
 -75.8%
H
1.0
61.4
|
L
 -96.9%
H
1.0
417
|
L
 -99.9%
H
1.0
18150
|
| Precision Optics Corp Inc |
|
48.9
|
4.5
|
L
 4.5%
H
4.2
4.6
|
L
 -3.7%
H
4.0
4.9
|
L
 2.5%
H
4.0
4.9
|
L
 -11.9%
H
4.0
5.3
|
L
 1.6%
H
3.6
6.2
|
L
 -25.7%
H
3.5
6.9
|
L
H
3.5
7.9
|
L
H
3.5
7.9
|
| Insulet |
|
9,133.3
|
131.7
|
L
 0.7%
H
128.0
132.5
|
L
 -3.3%
H
128.0
135.4
|
L
 -10.7%
H
128.0
147.4
|
L
 -19.9%
H
126.4
172.9
|
L
 -57.4%
H
126.4
354.9
|
L
 -13.4%
H
125.8
354.9
|
L
 -52.9%
H
125.8
354.9
|
L
 232.0%
H
30.7
354.9
|
| Procept BioRobotics Corp |
|
982.8
|
17.2
|
L
 0.8%
H
17.0
17.9
|
L
 -0.2%
H
16.7
18.7
|
L
 -24.6%
H
16.7
22.6
|
L
 -18.4%
H
16.7
22.9
|
L
 -52.3%
H
16.7
38.1
|
L
 -44.7%
H
16.7
103.8
|
L
 -55.2%
H
15.4
103.8
|
L
H
15.4
103.8
|
| Profound Medical Corp |
|
213.4
|
5.8
|
L
 -0.2%
H
5.8
6
|
L
 1.4%
H
5.6
6
|
L
 -15.2%
H
5.5
6.9
|
L
 -14.2%
H
5.5
8.5
|
L
 2.8%
H
4.8
9.0
|
L
 -38.3%
H
3.8
11.7
|
L
 -57.4%
H
3.1
15.5
|
L
 -38.6%
H
0.0
29.0
|
| QuidelOrtho Corporation |
|
738.6
|
10.8
|
L
 3.8%
H
10.5
11.2
|
L
 -1.6%
H
9.9
11.2
|
L
 -22.9%
H
9.9
14
|
L
 -41.0%
H
9.9
19.0
|
L
 -64.1%
H
9.9
35.6
|
L
 -85.5%
H
9.9
75.9
|
L
 -92.2%
H
9.9
180.1
|
L
 -50.2%
H
9.9
306.7
|
| Quanterix Corp |
|
172.1
|
3.6
|
L
 6.7%
H
3.4
3.7
|
L
 11.3%
H
3.2
3.7
|
L
 35.3%
H
2.4
3.7
|
L
 -15.9%
H
2.2
4.5
|
L
 -40.1%
H
2.2
8.8
|
L
 -86.1%
H
2.2
29.7
|
L
 -92.4%
H
2.2
60.9
|
L
H
2.2
92.6
|
| AVITA Medical Inc |
|
393.4
|
12.7
|
L
 5.9%
H
12.0
12.8
|
L
 7.4%
H
11.3
12.8
|
L
 13.6%
H
9.6
12.8
|
L
 151.4%
H
3.8
12.8
|
L
 129.6%
H
3.2
12.8
|
L
 14.1%
H
3.2
18.9
|
L
 -27.9%
H
3.2
21.7
|
L
 66.3%
H
3.2
55.4
|
| Rosecliff Acq Corp I (Class A) |
|
-
|
1.7
|
L
H
1.6
1.7
|
L
 4.4%
H
1.6
1.7
|
L
 5.7%
H
1.5
1.7
|
L
 -7.3%
H
1.5
1.9
|
L
 -25.6%
H
1.2
3.0
|
L
 -47.5%
H
1.2
4.7
|
L
 -83.0%
H
1.2
19.5
|
L
H
1.2
19.5
|
| Rockwell Medical Inc |
|
34.9
|
8.7
|
L
 0.9%
H
8.5
8.7
|
L
 3.4%
H
8.3
8.7
|
L
 8.4%
H
7.3
8.9
|
L
 56.1%
H
5.4
8.9
|
L
 -29.1%
H
4.9
12.9
|
L
 -58.2%
H
4.9
51.5
|
L
 -86.0%
H
4.9
71.5
|
L
 -98.8%
H
4.9
987.8
|
| Vyome Holdings Inc |
|
13.4
|
1.9
|
L
 -0.5%
H
1.8
2.0
|
L
 -6.4%
H
1.8
2.1
|
L
 -14.0%
H
1.8
2.2
|
L
 -17.0%
H
1.8
2.4
|
L
 -65.3%
H
1.8
6.6
|
L
 -89.8%
H
0.3
34.2
|
L
 -100.0%
H
0.3
9773
|
L
H
0.3
1381560
|
| Rewalk Robotics Ltd |
|
351.6
|
5.9
|
L
 -1.9%
H
5.9
6.4
|
L
 -16.3%
H
5.2
7
|
L
 -16.2%
H
5.2
7.4
|
L
 -27.1%
H
5.2
9.6
|
L
 650%
H
0.4
9.6
|
L
 15.2%
H
0.4
9.6
|
L
 -36.2%
H
0.4
13.7
|
L
 -99.4%
H
0.4
1137.5
|
| Sight Sciences Inc |
|
469.9
|
8.5
|
L
 -5.5%
H
8.5
9.1
|
L
 -4.5%
H
8.5
9.7
|
L
 2.2%
H
7.7
9.7
|
L
 56.5%
H
4.4
9.7
|
L
 159.3%
H
3.2
9.7
|
L
 139.6%
H
1.0
9.7
|
L
 -64.5%
H
1.0
27.7
|
L
H
1.0
42.6
|
| Sotera Health Co |
|
5,199.5
|
18.2
|
L
 0.6%
H
18.0
18.5
|
L
 -0.7%
H
18.0
18.8
|
L
 -3.6%
H
18.0
19.6
|
L
 1.6%
H
16.8
19.8
|
L
 14.2%
H
13.1
19.9
|
L
 25.1%
H
9.5
19.9
|
L
 -29.4%
H
5.8
27.4
|
L
H
5.8
30.4
|
| SI-BONE Inc |
|
810.3
|
18.1
|
L
 -1.8%
H
18.0
18.8
|
L
 -2.7%
H
18.0
19.6
|
L
 -2.3%
H
17.8
19.6
|
L
 5.7%
H
16.3
20.3
|
L
 24.7%
H
11.5
21.9
|
L
 -12.0%
H
11.5
22.6
|
L
 -12.4%
H
11.1
29.5
|
L
H
7.2
37.2
|
| SINTX Tech Inc |
|
14.7
|
2.2
|
L
 3.8%
H
2.1
2.3
|
L
 17.6%
H
1.9
2.4
|
L
 35.6%
H
1.6
2.4
|
L
 16.3%
H
1.4
2.4
|
L
 -43.9%
H
1.4
4.6
|
L
 -98.5%
H
0.1
180
|
L
 -100.0%
H
0.1
27200
|
L
 -100.0%
H
0.1
7848000
|
| Beauty Health Co (Class A) |
|
82.0
|
0.6
|
L
H
0.6
0.7
|
L
 -4.6%
H
0.6
0.7
|
L
 -7.4%
H
0.6
0.8
|
L
 -13.7%
H
0.6
1.2
|
L
 -62.5%
H
0.6
1.8
|
L
 -88.8%
H
0.6
5.9
|
L
 -97.6%
H
0.6
30.2
|
L
H
0.6
30.2
|
| Sanara MedTech Inc |
|
320.2
|
34.9
|
L
 -0.1%
H
34.6
34.9
|
L
 -0.6%
H
34.6
35.2
|
L
 0.4%
H
34.6
35.3
|
L
 40.3%
H
23
35.3
|
L
 11.7%
H
16.1
35.3
|
L
 13.1%
H
16.1
43.3
|
L
 2.2%
H
16.1
50.2
|
L
 729.8%
H
2
75
|
| Sensus Healthcare Inc |
|
49.1
|
3.0
|
L
 1.0%
H
2.9
3.1
|
L
 1.4%
H
2.9
3.1
|
L
 -6.6%
H
2.9
3.4
|
L
 -2.9%
H
2.8
3.7
|
L
 -13.1%
H
2.7
5.5
|
L
 15.1%
H
1.8
9.3
|
L
 -19.5%
H
1.8
15.3
|
L
 -52.6%
H
1.8
15.3
|
| Staar Surgical Co. |
|
1,126.7
|
22.5
|
L
 0.4%
H
22.1
22.8
|
L
 9.6%
H
20.2
23.0
|
L
 -4.3%
H
19.1
24.4
|
L
 -19.1%
H
19.1
29.9
|
L
 -17.2%
H
15.6
35.9
|
L
 -42.0%
H
13.5
52.7
|
L
 -80.7%
H
13.5
128.3
|
L
 142.9%
H
7.5
163.1
|
| Neuronetics Inc |
|
164.6
|
2.2
|
L
 -2.7%
H
2.1
2.3
|
L
 -21.2%
H
2.1
2.7
|
L
 -25%
H
2.1
3.3
|
L
 53.2%
H
1.4
3.4
|
L
 -24.2%
H
0.8
3.4
|
L
 84.6%
H
0.5
5.9
|
L
 -65.8%
H
0.5
7.0
|
L
H
0.5
39.4
|
| SkyAI Inc |
|
79.6
|
1.8
|
L
 -5.2%
H
1.8
2.1
|
L
 -2.1%
H
1.7
2.1
|
L
 33.3%
H
1.2
2.1
|
L
 49.6%
H
1.0
2.1
|
L
 -72.7%
H
0.9
6.9
|
L
 -99.9%
H
0.0
5446.3
|
L
H
0.0
23892
|
L
H
0.0
23892
|
| Tactile Systems Tech Inc |
|
500.6
|
22.1
|
L
 1.8%
H
21.6
22.4
|
L
 -2.8%
H
21.6
23.3
|
L
 1.1%
H
21.3
23.3
|
L
 -29.5%
H
21.3
32.4
|
L
 45.4%
H
14
37.8
|
L
 64.2%
H
8.6
37.8
|
L
 -51.3%
H
6.3
46.1
|
L
 21.8%
H
6.3
76.6
|
| TELA Bio Inc |
|
51.5
|
1.1
|
L
 -8.8%
H
1.1
1.3
|
L
 -9.5%
H
1.1
1.3
|
L
 39.0%
H
0.8
1.5
|
L
 58.3%
H
0.6
1.5
|
L
 -26.9%
H
0.5
1.6
|
L
 -84.4%
H
0.5
7.8
|
L
 -91.3%
H
0.5
14
|
L
H
0.5
23.5
|
| Valion Bio Inc |
|
2.3
|
2.6
|
L
 3.2%
H
2.5
2.7
|
L
 -14.5%
H
2.4
4.4
|
L
 -6.5%
H
2.1
4.4
|
L
 -79.3%
H
2.1
32.5
|
L
 -96.6%
H
2.1
78.8
|
L
 -99.6%
H
2.1
1364.2
|
L
H
2.1
276250
|
L
H
2.1
276250
|
| Treace Medical Concepts Inc |
|
285.5
|
4.4
|
L
 1.4%
H
4.2
4.4
|
L
 -2.4%
H
4.2
4.6
|
L
 -8.7%
H
4.2
4.9
|
L
 4.3%
H
3.9
5.2
|
L
 -31.0%
H
1.2
7.1
|
L
 -63.4%
H
1.2
16.0
|
L
 -82.5%
H
1.2
28.0
|
L
H
1.2
37.2
|
| Transmedics Grp Inc |
|
2,767.1
|
79.8
|
L
 1.5%
H
77.1
80.9
|
L
 -6.4%
H
77.1
86.4
|
L
 -11.3%
H
77.1
90.7
|
L
 15.9%
H
68
95.2
|
L
 -31.0%
H
60.1
156
|
L
 51.9%
H
36.4
177.4
|
L
 171.7%
H
10
177.4
|
L
H
10
177.4
|
| Tandem Diabetes Care Inc |
|
1,148.0
|
16.5
|
L
H
16.3
17.4
|
L
 5.0%
H
15.5
17.4
|
L
 -17.1%
H
14.8
20.6
|
L
 7.7%
H
14.6
24.8
|
L
 12.2%
H
12.3
29.7
|
L
 -18.9%
H
10.0
53.7
|
L
 -86.0%
H
10.0
155.9
|
L
 -78.4%
H
2.1
155.9
|
| Trinity Biotech PLC (ADR) |
|
4.6
|
5.7
|
L
 -10.0%
H
5.1
5.8
|
L
 -15.8%
H
5.0
7.5
|
L
 -39.5%
H
5.0
9.7
|
L
 -49.7%
H
5.0
14.2
|
L
 -83.5%
H
5.0
52.5
|
L
 -100.0%
H
5.0
12562.5
|
L
 -100.0%
H
5.0
46875
|
L
 -100.0%
H
5.0
138750
|
| Utah Medical Products Inc |
|
235.3
|
74.1
|
L
 -0.3%
H
74.1
74.4
|
L
 -0.1%
H
73.8
75.0
|
L
 4.3%
H
68.5
76.9
|
L
 1.9%
H
63.8
76.9
|
L
 17.1%
H
53.7
76.9
|
L
 -14.5%
H
51.3
88.0
|
L
 -18.3%
H
51.3
133.9
|
L
 24.3%
H
51.3
133.9
|
| Vivani Medical Inc |
|
111.0
|
1.2
|
L
 0.8%
H
1.2
1.3
|
L
 -0.8%
H
1.2
1.3
|
L
 -17.5%
H
1.2
1.5
|
L
 -2.4%
H
1.2
1.7
|
L
 -12.1%
H
0.9
1.9
|
L
 19.4%
H
0.8
7.8
|
L
 -86.4%
H
0.8
10.3
|
L
 -98.5%
H
0.8
84.2
|
| Veracyte Inc |
|
3,682.7
|
45.8
|
L
 3.7%
H
44.4
46.1
|
L
 0.8%
H
44.2
47.5
|
L
 7.7%
H
38.2
49
|
L
 -19.7%
H
38.2
60.8
|
L
 27.3%
H
29.5
60.9
|
L
 113.3%
H
18.6
60.9
|
L
 6.0%
H
14.9
60.9
|
L
 511.6%
H
5.2
86.0
|
| Varex Imaging Corp |
|
783.9
|
18.5
|
L
 -0.2%
H
18.5
18.5
|
L
 0.1%
H
18.4
18.5
|
L
 -0.3%
H
18.4
18.5
|
L
 74.0%
H
10.0
18.6
|
L
 54.6%
H
9.1
18.6
|
L
 -2.3%
H
6.8
21.5
|
L
 -35.7%
H
6.8
32.7
|
L
H
6.8
43.8
|
| Vivos Therapeutics Inc |
|
3.0
|
0.2
|
L
H
0.2
0.2
|
L
 7.1%
H
0.1
0.2
|
L
 -21.1%
H
0.1
0.2
|
L
 -66.7%
H
0.1
0.5
|
L
 -95.3%
H
0.1
3.4
|
L
 -98.0%
H
0.1
48.8
|
L
 -99.8%
H
0.1
106.8
|
L
H
0.1
360.3
|
| Wrap Tech Inc |
|
90.8
|
1.5
|
L
 2.8%
H
1.5
1.5
|
L
 1.4%
H
1.3
1.5
|
L
 -12.0%
H
1.3
1.7
|
L
 4.3%
H
1.3
2.7
|
L
 -46.9%
H
1.0
3.2
|
L
 -1.3%
H
1.0
7.0
|
L
 -74.2%
H
1.0
7.0
|
L
H
1.0
14.4
|
| Beyond Air Inc |
|
2.8
|
2.8
|
L
 -3.8%
H
2.8
3.0
|
L
 -1.1%
H
2.4
3.0
|
L
 -20.1%
H
2.4
3.6
|
L
 -69.9%
H
2.4
9.4
|
L
 -94.2%
H
2.4
55.6
|
L
 -99.7%
H
2.4
1044
|
L
 -99.9%
H
2.4
6564
|
L
 -100.0%
H
2.4
6564
|
| DENTSPLY Sirona Inc |
|
1,728.4
|
8.7
|
L
 -0.8%
H
8.6
8.9
|
L
 -7.8%
H
8.6
9.3
|
L
 -23.8%
H
8.6
11.3
|
L
 -25.6%
H
8.6
14.4
|
L
 -34.3%
H
8.6
14.8
|
L
 -74.0%
H
8.6
37.6
|
L
 -85.0%
H
8.6
59.5
|
L
 -85.3%
H
8.6
69.5
|
| X.T.L. Biopharma Ltd (ADR) |
|
5.3
|
2.2
|
L
 1.4%
H
2.2
2.2
|
L
 -1.8%
H
2.1
2.4
|
L
 -14.6%
H
2.1
2.6
|
L
 -20%
H
2.1
3.5
|
L
 -88.5%
H
2.0
41.1
|
L
 -85.8%
H
2.0
79.8
|
L
 -96.9%
H
2.0
79.8
|
L
 -97.1%
H
2.0
107.0
|
| Jin Medical Intl Ltd |
|
299.6
|
1.9
|
L
 -3%
H
1.9
2.0
|
L
 1.6%
H
1.9
2.1
|
L
 -6.7%
H
1.8
2.3
|
L
 -1.0%
H
1.5
3.7
|
L
 -83.4%
H
1.5
12
|
L
 -93.1%
H
1.5
509.9
|
L
H
1.5
509.9
|
L
H
1.5
509.9
|
| HeartBeam Inc |
|
24.8
|
0.4
|
L
 4.8%
H
0.4
0.5
|
L
 22.2%
H
0.4
0.5
|
L
 2.3%
H
0.4
0.5
|
L
 -38.9%
H
0.4
0.7
|
L
 -77.4%
H
0.4
4
|
L
 -72.2%
H
0.4
4
|
L
 -72.2%
H
0.4
4
|
L
 -72.2%
H
0.4
4
|
| TriSalus Life Sciences Inc |
|
266.0
|
4.3
|
L
 4.1%
H
4.0
4.5
|
L
 -0.5%
H
4.0
4.5
|
L
 -13.6%
H
4.0
5.8
|
L
 -7.9%
H
3.7
5.9
|
L
 -6.5%
H
2.2
8.0
|
L
 -15.3%
H
2.2
10.4
|
L
 -36.2%
H
2.2
10.4
|
L
 -36.2%
H
2.2
10.4
|
| Spectral AI Inc (Class A) |
|
53.4
|
1.7
|
L
H
1.6
1.7
|
L
 4.4%
H
1.6
1.7
|
L
 5.7%
H
1.5
1.7
|
L
 -7.3%
H
1.5
1.9
|
L
 -25.6%
H
1.2
3.0
|
L
 -47.5%
H
0.8
4.7
|
L
H
0.8
13
|
L
H
0.8
13
|
| Envoy Medical Inc (Class A) |
|
52.6
|
0.7
|
L
 3.0%
H
0.7
0.7
|
L
 -5.6%
H
0.7
0.7
|
L
 -4.2%
H
0.7
0.8
|
L
 -9.3%
H
0.6
0.8
|
L
 -16.1%
H
0.4
1.9
|
L
 -83.5%
H
0.4
11.5
|
L
H
0.4
11.5
|
L
H
0.4
11.5
|
| Autonomix Medical Inc |
|
7.4
|
3.8
|
L
 -3.6%
H
3.6
4.0
|
L
 -6.0%
H
3.6
4.2
|
L
 -17.7%
H
3.6
4.8
|
L
 -41.2%
H
2.4
24.7
|
L
 -84.2%
H
2.4
32.6
|
L
H
2.4
3192
|
L
H
2.4
3192
|
L
H
2.4
3192
|
| Rewalk Robotics Ltd |
|
16.6
|
5.9
|
L
 -1.9%
H
5.9
6.4
|
L
 -16.3%
H
5.2
7
|
L
 -16.2%
H
5.2
7.4
|
L
 -27.1%
H
5.2
9.6
|
L
 -37.4%
H
4.1
10.2
|
L
 -90.4%
H
4.1
109.2
|
L
 -94.7%
H
4.1
163.8
|
L
 -100.0%
H
4.1
13650
|
| GRAIL Inc |
|
6,398.9
|
143.3
|
L
 8.1%
H
134.5
143.5
|
L
 12.9%
H
126.7
151.5
|
L
 78.3%
H
73.5
151.5
|
L
 107.3%
H
60.8
151.5
|
L
 118.6%
H
41.5
151.5
|
L
H
12.6
151.5
|
L
H
12.6
151.5
|
L
H
12.6
151.5
|
| Work Medical Tech Grp Ltd |
|
7.6
|
1.7
|
L
 -2.8%
H
1.7
1.8
|
L
 -10.5%
H
1.7
1.9
|
L
 -18.6%
H
1.7
2.2
|
L
 -22.6%
H
1.7
3.2
|
L
 -100%
H
1.7
105000
|
L
H
1.7
8446000
|
L
H
1.7
8446000
|
L
H
1.7
8446000
|
| iTonic Holdings Ordinary |
|
4.3
|
0.3
|
L
 -13.8%
H
0.2
0.3
|
L
 -13.8%
H
0.2
0.3
|
L
 -21.9%
H
0.2
0.5
|
L
 -16.7%
H
0.2
0.5
|
L
 -68.4%
H
0.2
1.2
|
L
H
0.2
32
|
L
H
0.2
32
|
L
H
0.2
32
|
| Ceribell Inc |
|
909.2
|
23.7
|
L
 0.3%
H
23.3
24.2
|
L
H
23.3
25.3
|
L
 -4.2%
H
23.0
25.6
|
L
 21.2%
H
16.0
25.6
|
L
 87.4%
H
10.9
25.6
|
L
H
10.0
32.8
|
L
H
10.0
32.8
|
L
H
10.0
32.8
|
| Anteris Tech Global Corp |
|
751.4
|
7.7
|
L
 1.3%
H
7.7
8
|
L
 0.3%
H
7.5
8
|
L
 -14.7%
H
7.5
9.0
|
L
 -24.7%
H
7.5
11.1
|
L
 78.9%
H
3.3
11.1
|
L
H
2.3
11.1
|
L
H
2.3
11.1
|
L
H
2.3
11.1
|
| Beta Bionics Inc |
|
1,022.8
|
19.0
|
L
 0.5%
H
18.3
19.3
|
L
 -11.9%
H
18.3
21.7
|
L
 -2.4%
H
15.5
23.6
|
L
 13.1%
H
12.7
23.6
|
L
 -14.8%
H
8.8
32.7
|
L
H
8.8
32.7
|
L
H
8.8
32.7
|
L
H
8.8
32.7
|
| Anbio biotech (Class A) |
|
243.6
|
5.6
|
L
 -11.8%
H
5.5
6.2
|
L
 -11.9%
H
5.5
6.6
|
L
 -15.1%
H
5.1
7.0
|
L
 -56.3%
H
5.1
13.8
|
L
 -82.7%
H
5.1
44.7
|
L
H
5.1
55.7
|
L
H
5.1
55.7
|
L
H
5.1
55.7
|
| Kestra Medical Tech Ltd |
|
1,633.8
|
27.4
|
L
 1.1%
H
26.8
27.8
|
L
 1.1%
H
26.8
29.7
|
L
 7.4%
H
21.6
29.7
|
L
 1.7%
H
20.4
29.7
|
L
 10.5%
H
17.3
30
|
L
H
13.3
30
|
L
H
13.3
30
|
L
H
13.3
30
|
| Sanuwave Health Inc |
|
41.5
|
4.8
|
L
 4.3%
H
4.7
4.8
|
L
 -4.4%
H
4.5
5.1
|
L
 10.1%
H
3.9
5.1
|
L
 -54.7%
H
3.9
13
|
L
 -87.1%
H
3.9
40.9
|
L
 -85.1%
H
3.9
46.6
|
L
 -85.1%
H
3.9
46.6
|
L
 -85.1%
H
3.9
46.6
|
| SS Innovations Intl Inc |
|
535.0
|
2.7
|
L
 -2.9%
H
2.7
2.9
|
L
 -9.5%
H
2.7
3.1
|
L
 -21.7%
H
2.7
3.5
|
L
 -29.4%
H
2.7
4.2
|
L
 -62.9%
H
2.7
10
|
L
H
2.7
22.4
|
L
H
2.7
22.4
|
L
H
2.7
22.4
|
| CapsoVision Inc |
|
328.3
|
6.2
|
L
 -2.4%
H
6.1
6.4
|
L
 -7.2%
H
6.1
7.0
|
L
 3.0%
H
5.9
7.0
|
L
 -15.3%
H
5.6
7.3
|
L
 28.8%
H
4.4
15.4
|
L
 76.3%
H
3.4
15.4
|
L
 76.3%
H
3.4
15.4
|
L
 76.3%
H
3.4
15.4
|
| Medline Inc Ordinary Shares |
|
31,242.5
|
35.6
|
L
 1.9%
H
34.9
35.7
|
L
 2.6%
H
34.0
35.8
|
L
 -2.7%
H
31.5
36.8
|
L
 -17.6%
H
31.5
43.6
|
L
 -13.2%
H
31.5
50.9
|
L
 -13.1%
H
31.5
50.9
|
L
 -13.1%
H
31.5
50.9
|
L
 -13.1%
H
31.5
50.9
|
| MiniMed Group Inc |
|
5,542.6
|
19.7
|
L
 0.5%
H
19.3
20.0
|
L
 -1.4%
H
19.3
20.5
|
L
 -15.4%
H
19.3
23.7
|
L
 26.4%
H
14.7
24.4
|
L
H
10.7
24.4
|
L
H
10.7
24.4
|
L
H
10.7
24.4
|
L
H
10.7
24.4
|
| Mobia Medical Inc |
|
305.6
|
9.2
|
L
 1.7%
H
8.8
9.3
|
L
 1.3%
H
8.6
9.6
|
L
 -21.1%
H
8.5
11.8
|
L
 -32.8%
H
8.5
13.9
|
L
 -21.9%
H
8.5
15.3
|
L
 -21.9%
H
8.5
15.3
|
L
 -21.9%
H
8.5
15.3
|
L
 -21.9%
H
8.5
15.3
|
| FocalTherics ADR |
|
198.3
|
4.2
|
L
 -2.8%
H
4.2
4.4
|
L
 -10.8%
H
4.2
4.8
|
L
 1.2%
H
4
4.8
|
L
 -18.9%
H
4
6.4
|
L
 -7.9%
H
4
6.4
|
L
 -7.9%
H
4
6.4
|
L
 -7.9%
H
4
6.4
|
L
 -7.9%
H
4
6.4
|